Domov › Rakovina prostaty › Oregon › Portland
Klinické štúdie Rakovina prostaty v meste Portland, OR
33 štúdií pre Rakovina prostaty hľadá účastníkov v zariadeniach v meste Portland a okolí (do cca 30 míľ). Otvorte štúdiu a zistite, kto sa môže zapojiť a ako kontaktovať tím.
Oficiálny text štúdie (anglicky)
Hľadáte účastníkov do štúdie? Zvýraznite ju na začiatku tejto stránky – $99 na 30 dní →
A Single-Arm Phase II Study of Neoadjuvant Intensified Androgen Deprivation (Leuprolide and Abiraterone Acetate) in Combination With AKT Inhibition (Capivasertib) for High-Risk Localized Prostate Cancer With PTEN Loss
Prebieha náborFáza 2
- VA Portland Health Care System, Portland, OR, Portland
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Prebieha náborFáza 1/2
- Oregon Health & Science University (OHSU), Portland
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
Prebieha náborFáza 3
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
Prebieha náborFáza 2
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
- Oregon Health and Science University, Portland
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
- Providence Willamette Falls Medical Center, Oregon City · 12 míľ odtiaľ
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Prebieha náborFáza 2
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
- Oregon Health and Science University, Portland
Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Management of Prostate Cancer Following Negative or Equivocal PSMA (Prostate-Specific Membrane Antigen) PET Imaging at the Time of Biochemical Recurrence
Prebieha náborFáza 4
- Oregon Health & Science University, Portland
Precision-Based Genomics in Prostate Cancer
Prebieha náborObservačná štúdia
- Oregon Health Sciences University, Portland
A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer
Prebieha náborFáza 1
- Oregon Health And Science University, Portland
A Phase 1 Study of BPX-601 CAR T-Cell Therapy in Adult Participants With Prostate Cancer That Has Returned, is Resistant to Treatment and Has Spread
Prebieha náborFáza 1
- Providence Portland Medical Center, Portland
Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
Prebieha náborFáza 2
- VA Portland Health Care System, Portland, OR, Portland
High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers
Prebieha náborFáza 2
- VA Portland Health Care System, Portland, OR, Portland
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
Prebieha náborFáza 3
- VA Portland Health Care System ( Site 0038), Portland
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Prebieha náborFáza 3
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
- Kaiser Permanente Northwest, Portland
MRI Risk Maps for Prostate Cancer Diagnosis Using Targeted Biopsy
Prebieha nábor
- Oregon Health & Science University, Portland
A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer
Prebieha náborFáza 2
- Oregon Health & Science University, Portland
Phase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate Cancer
Prebieha náborFáza 1/2
- Research Site, Portland
AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
Prebieha náborFáza 3
- Research Site, Portland
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Prebieha náborFáza 3
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
- Oregon Health and Science University, Portland
- a 1 ďalších
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Prebieha náborFáza 1/2
- Oregon Health and Science University, Portland
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Prebieha náborFáza 3
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
- Oregon Health and Science University, Portland
- a 1 ďalších
A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancer
Prebieha náborFáza 1/2
- Oregon Health & Science University, Portland
Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.
Prebieha náborFáza 2
- VA Portland Health Care System, Portland
International Registry for Men With Advanced Prostate Cancer (IRONMAN)
Prebieha náborObservačná štúdia
- Oregon Health & Science University Hospital, Portland
Prostate Cancer Screening for People at Genetic Risk for Aggressive Disease, PATROL Study
Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov
- OHSU Knight Cancer Institute, Portland
A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate Cancer
Prebieha náborFáza 1
- Research Site, Portland
Internet-Based Lifestyle Intervention to Eradicate Obese Frailty in Prostate Cancer Survivors, iLIVE
Prebieha nábor
- OHSU Knight Cancer Institute, Portland
GET FIT Together: Testing a Socially Enhanced Exercise Program in Older Men With Prostate Cancer
Prebieha nábor
- OHSU Knight Cancer Institute, Portland
Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation
Prebieha náborFáza 2
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
- Oregon Health and Science University, Portland
- a 1 ďalších
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov
- Oregon Health Sciences University, Portland
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Prebieha náborObservačná štúdia
- Massive Bio SYNERGY-AI site, Portland
EMBRACE: Exercising Together
Prebieha náborFáza 2Vítaní zdravých dobrovoľníkov
- OHSU Knight Cancer Institute, Portland
Neoadjuvant Pembrolizumab Plus Androgen Axis Blockade Prior to Prostatectomy for High Risk Localized Prostate Cancer
Prebieha náborFáza 2
- VA Portland Healthcare System, Portland
Štúdie Rakovina prostaty v iných mestách
- New York City, NY103 štúdií
- Houston, TX76 štúdií
- Los Angeles, CA61 štúdií
- Boston, MA59 štúdií
- St. Louis, MO46 štúdií
- Chicago, IL45 štúdií
- San Francisco, CA45 štúdií
- Philadelphia, PA44 štúdií
- Baltimore, MD43 štúdií
- Nashville, TN43 štúdií
- Seattle, WA42 štúdií
- Washington, DC38 štúdií
Iné štúdie v Portland
- Nemalobunkový karcinóm pľúc46 štúdií
- Rakovina (všetky typy)34 štúdií
- Rakovina prsníka33 štúdií
- Metastatická rakovina29 štúdií
- Kolorektálny karcinóm28 štúdií
- Rakovina vaječníkov27 štúdií
- Rakovina pľúc26 štúdií
- Akútna myeloidná leukémia25 štúdií
- Rakovina endometria24 štúdií
- Skvamóznocelulárny karcinóm hlavy a krku19 štúdií
- Rakovina pankreasu19 štúdií
- Srdcové zlyhanie17 štúdií
Z ClinicalTrials.gov, dáta načítané 6. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.